Adverse drug event rates in pediatric pulmonary hypertension: a comparison of real-world data sources

摘要

Objective: Real-world data (RWD) are increasingly used for pharmacoepidemiology and regulatory innovation. Our objective was to compare adverse drug event (ADE) rates determined from two RWD sources, electronic health records and administrative claims data, among children treated with drugs for pulmonary hypertension.